Cheminformatic Tools and Databases for Pharmacology

session 10945 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
ZIPRASIDONE

ZIPRASIDONE


ATC N05AE04

NERVOUS SYSTEM
TREATMENT OF BIPOLAR DISORDER
ANTIPSYCHOTIC
DOPAMINE D2 (KI = 4.8 NANOMOLAR) AND D3 (KI = 7.2 NANOMOLAR) ANTAGONISTS
SEROTONIN 5HT2A (KI = 0.4 NANOMOLAR) 5HT2C (KI = 1.3 NANOMOLAR) 5HT1D (KI = 2 NANOMOLAR) ANTAGONISTS
ALPHA 1 ADRENERGIC RECEPTOR (KI = 10 NANOMOLAR) ANTAGONISTS
5HT1A RECEPTOR AGONIST (KI = 3.4 NANOMOLAR)

ORAL INTRAMUSCULAR

Tmax 7 HOUR

F 60 PERCENT

VD 97.5 LITER (65 KILOGRAM)

PPB 99 PERCENT

Cl 29.2 LITER / HOUR (65 KILOGRAM)

HT 7 HOUR

ALPHA 1 ADRENERGIC RECEPTOR
5-HYDROXYTRYPTAMINE 1A RECEPTOR
D(2) DOPAMINE RECEPTOR
5-HYDROXYTRYPTAMINE 2A RECEPTOR
5-HYDROXYTRYPTAMINE 2C RECEPTOR
D(3) DOPAMINE RECEPTOR
5-HYDROXYTRYPTAMINE 1D RECEPTOR

DOPAMINE D2 RECEPTOR ANTAGONIST CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |